Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Nazan GÜNEL"'
Autor:
Volkan Aslan, Atiye Cenay Karabörk Kılıç, Ahmet Özet, Aytuğ Üner, Nazan Günel, Ozan Yazıcı, Gözde Savaş, Ahmet Bayrak, Emrah Eraslan, Berna Öksüzoğlu, Hüseyin Koray Kılıç, Nuriye Özdemir
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of cancer types. An important deficiency in immunooncology today is the lack of a predic
Externí odkaz:
https://doaj.org/article/064c7efbc4eb4b068e1b246c055dc512
Publikováno v:
Turkish Journal of Medical Sciences. 53:142-148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32c0dac138e8df1bd30b80a033838b2c
https://doi.org/10.55730/1300-0144.5567
https://doi.org/10.55730/1300-0144.5567
Autor:
Osman SÜTCÜOĞLU, Mehmet Arda İNAN, Aytuğ ÜNER, Gözde SAVAŞ, Hüseyin BORA, Ahmet ÖZET, Nazan GÜNEL, Nalan AKYÜREK, Ozan YAZICI, Nuriye ÖZDEMİR
Publikováno v:
Journal of Oncological Sciences. 9:23-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::870fbc4cabac64ad111256617099e62a
https://doi.org/10.37047/jos.2022-94374
https://doi.org/10.37047/jos.2022-94374
Autor:
Kadriye Bir Yücel, Zeynep Irem Özay, Osman Sütcüoğlu, Ozan Yazıcı, Aytug Üner, Nazan Günel, Ahmet Özet, Gözde Savaş, Nuriye Özdemir
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.Purpose: This study aims to investigate the factors that influence financial toxicity and its effects on both quality of life and psychological d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846948938be585238e88a064fa163b2a
https://avesis.gazi.edu.tr/publication/details/666bd8c7-fd33-43bc-bcd6-d73262425701/oai
https://avesis.gazi.edu.tr/publication/details/666bd8c7-fd33-43bc-bcd6-d73262425701/oai
Autor:
Nuriye Ozdemir, Ozan Yazıcı, Oktay Ünsal, Aytug Uner, Osman Sütcüoğlu, Bediz Kurt Inci, Nazan Günel, Demet Döndü Kasım, Gözde Tahtaci, Ahmet Ozet, Volkan Aslan, Fatih Gürler
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1516-1523
Introduction To evaluate biosimilar understanding and preference trends of medical oncologists in Turkey. Methods A survey consisting of 24 multiple-choice questions with checkbox answers was conducted among medical oncologists. The questionnaire was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2000f8aa9d9fdb933ef420e2bcd81be7
https://doi.org/10.1177/10781552211031643
https://doi.org/10.1177/10781552211031643
Autor:
Dogan Uncu, Gokhan Ucar, Deniz Can Guven, Deniz Tural, Nazan Günel, Ozan Yazıcı, Nuriye Ozdemir, Aytug Uner, Osman Sütcüoğlu, Omur Berna Oksuzoglu, Seher Yildiz Tacar, Saadettin Kilickap, Aysegul Ilhan, Ahmet Ozet, Fatih Yildiz, Emrah Eraslan, Nuri Karadurmus
Publikováno v:
Immunotherapy. 13(17)
Background: The aim of this study was to determine the cause of death in patients who died within 30 days after the first dose of immunotherapy. Methods: The data of 1432 patients treated with immunotherapy in six tertiary referral hospitals were ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36977f997360d832152fa7093fb35c6
https://pubmed.ncbi.nlm.nih.gov/34676791
https://pubmed.ncbi.nlm.nih.gov/34676791
Autor:
Volkan Aslan, Atiye Cenay Karabörk Kılıç, Osman Sütcüoğlu, Emrah Eraslan, Ahmet Bayrak, Berna Öksüzoğlu, Gözde Tahtacı, Nuriye Özdemir, Aytuğ Üner, Nazan Günel, Ahmet Özet, Ozan Yazıcı
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:494.e1-494.e10
Immune checkpoint inhibitors (ICI) have transformed treatments for patients with metastatic renal cell carcinoma (mRCC). Although some patients benefit greatly from ICI treatments, an effective marker to determine which patients will benefit from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa533669458a77ef0525ac268e0a8e22
https://doi.org/10.1016/j.urolonc.2022.07.018
https://doi.org/10.1016/j.urolonc.2022.07.018
Autor:
Osman Sütcüoğlu, Nuriye Ozdemir, Sadettin Kilickap, Deniz Tural, O.B. Cakmak Oksuzoglu, Aytug Uner, Ahmet Ozet, A İlhan, Ozan Yazıcı, Seher Yildiz Tacar, Dogan Uncu, Nuri Karadurmus, Gokhan Ucar, Nazan Günel, Fatih Yildiz, Deniz Can Guven, Emrah Eraslan
Publikováno v:
Annals of Oncology. 32:S837
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6312e7ea98c2e2b3bce81cde07d0a4b1
https://doi.org/10.1016/j.annonc.2021.08.1360
https://doi.org/10.1016/j.annonc.2021.08.1360
Autor:
Mehmet, Dağlı, Taner, Demirer, Meltem, Aylı, Rauf, Haznedar, Nazan, Günel, Gülsan, Sucak, Turgay, Fen, Meltem, Moran, Tülay, Üstün, Celalettin, Aybirdi, Mustafa, Çavuşoğlu, Süleyman, Dinçer, Akın, Uysal
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 19(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c53a20328a1709823974b76d1945739b
https://pubmed.ncbi.nlm.nih.gov/27265191
https://pubmed.ncbi.nlm.nih.gov/27265191
Autor:
Neslihan Bukan, Ugur Coskun, Banu Sancak, Nazan Günel, Yesim Yildirim, Sabahattin Aslan, Abdullah Çetin
Publikováno v:
International Immunopharmacology. 8:1119-1123
Endothelin-1 [ET-1] acts as a growth factor in various malignancies. Big endothelin-1 (big ET-1) is the precursor of ET-1. The aim of this study was to determine the importance of serum big ET-1 levels as a novel marker of disease in female patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552e7e4c6e9ae5776e821ab7ca77188d
https://doi.org/10.1016/j.intimp.2008.03.023
https://doi.org/10.1016/j.intimp.2008.03.023